Today: 2 May 2026
Browse Category

NASDAQ:ATRA 12 January 2026 - 9 March 2026

Atara Biotherapeutics Stock Jumps 18% as FDA Shake-Up Puts Ebvallo Back in Focus

Atara Biotherapeutics Stock Jumps 18% as FDA Shake-Up Puts Ebvallo Back in Focus

Atara Biotherapeutics shares jumped 18% Monday after reports that FDA biologics chief Vinay Prasad will depart in April. The move follows the agency’s January rejection of Atara’s EBVALLO therapy for a rare blood cancer, which wiped out 56% of the stock’s value. Atara and partner Pierre Fabre have requested a Type A meeting with the FDA to revisit the decision. Atara ended 2025 with $8.5 million in cash.
9 March 2026
····
Atara Biotherapeutics stock dives on FDA EBVALLO rejection — what ATRA investors watch next

Atara Biotherapeutics stock dives on FDA EBVALLO rejection — what ATRA investors watch next

Atara Biotherapeutics shares fell 56% after the FDA rejected its cell therapy EBVALLO for a rare post-transplant cancer, citing insufficient evidence from the single-arm ALLELE study. The agency said previous manufacturing issues were resolved but requested new efficacy data. Atara and partner Pierre Fabre plan expedited talks with the FDA. The company reported $8.5 million in cash at year-end.
12 January 2026
··

Stock Market Today

  • Adisoft Technologies Shares List 19% Above IPO Price on NSE SME Platform
    May 1, 2026, 10:36 PM EDT. Adisoft Technologies shares debuted strong on the NSE SME platform, listing at Rs 205, a 19% premium over the Rs 172 IPO price. Despite zero grey market premium suggesting muted expectations, the Rs 74 crore IPO was subscribed 77 times, led by institutional and high-net-worth investors. Adisoft operates in industrial automation, offering digital solutions for automobile manufacturing. IPO proceeds aim to fund a new manufacturing facility, repay debt, and support working capital. Profits rose to Rs 16.1 crore in FY25, while revenue showed volatility due to project-based business. Market caution stems from global uncertainties and the SME segment's mixed listing outcomes. Long-term growth hinges on scaling operations, securing orders, and maintaining margins amid competition.

Latest article

US Stock Market Today After Hours: Nasdaq Tops 25,000 As S&P 500 Hits Record High

US Stock Market Today After Hours: Nasdaq Tops 25,000 As S&P 500 Hits Record High

2 May 2026
Nasdaq 100 futures climbed 0.68% and S&P 500 futures edged up 0.06% in early after-hours trading Friday, while Dow futures slipped 0.48%. The S&P 500 and Nasdaq closed at record highs, driven by first-quarter S&P 500 profit growth of 27.8%, according to LSEG. Oil prices, inflation signals, and upcoming jobs data remain in focus. GameStop shares rose 4% after reports it was preparing an offer for eBay.
McDonald’s Corporation Stock Slides Before Earnings as Its Big Drink Bet Comes Due

McDonald’s Corporation Stock Slides Before Earnings as Its Big Drink Bet Comes Due

2 May 2026
McDonald’s shares fell 2.37% to $286.64 on Friday, underperforming rivals ahead of its May 7 earnings report and a U.S. launch of six new McCafé specialty drinks. The company will begin selling the drinks nationwide on May 6, adding beverage specialist roles at 14,000 restaurants. Investors are watching whether the new drinks and value offers can boost traffic without slowing service or hurting margins.
Strategy Inc’s 11.5% STRC Payout Sets Up Bitcoin Dividend Vote

Strategy Inc’s 11.5% STRC Payout Sets Up Bitcoin Dividend Vote

2 May 2026
Strategy Inc kept STRC’s May dividend rate at 11.5% and set a $0.958333333 per-share payout, according to a new filing. Shareholders are voting on whether to move STRC dividends from monthly to twice monthly, with results due at the June 8 annual meeting. The company recently used $255 million from a stock sale to buy 3,273 bitcoin.
Go toTop